Goldman Sachs Group Inc

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-34.7%

median move per position

+10.6%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

1 position still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$10.33M bought · −$17.30M sold

All filings on record

Every Form 4 transaction we track for this filer

All10Buys1Sells7

Stock	Transaction	Date	~6mo vs S&P
ATTOAttovia Therapeutics, Inc.	Buy $8.50M · 500,000 sh	2026-08-06	—
ATTOAttovia Therapeutics, Inc.	Convert — · 478,498 sh	2026-08-06	—
ATTOAttovia Therapeutics, Inc.	Convert — · 1,957,134 sh	2026-08-06	—
ATTOAttovia Therapeutics, Inc.	Sell $1.61M · 76,418 sh	2026-08-05	—
ATTOAttovia Therapeutics, Inc.	Sell $146.1K · 6,763 sh	2026-08-05	—
ATTOAttovia Therapeutics, Inc.	Sell $2.2K · 100 sh	2026-08-05	—
ATTOAttovia Therapeutics, Inc.	Sell $25.8K · 1,163 sh	2026-08-05	—
ATTOAttovia Therapeutics, Inc.	Sell $15.4K · 700 sh	2026-08-05	—
ATTOAttovia Therapeutics, Inc.	Sell $4.4K · 200 sh	2026-08-05	—
ATTOAttovia Therapeutics, Inc.	Sell $9.6K · 443 sh	2026-08-05	—

ATTOBuy

2026-08-06 · Attovia Therapeutics, Inc.

$8.50M

—

ATTOConvert

2026-08-06 · Attovia Therapeutics, Inc.

478,498

—

ATTOConvert

2026-08-06 · Attovia Therapeutics, Inc.

1,957,134

—

ATTOSell

2026-08-05 · Attovia Therapeutics, Inc.

$1.61M

—

ATTOSell

2026-08-05 · Attovia Therapeutics, Inc.

$146.1K

—

ATTOSell

2026-08-05 · Attovia Therapeutics, Inc.

$2.2K

—

ATTOSell

2026-08-05 · Attovia Therapeutics, Inc.

$25.8K

—

ATTOSell

2026-08-05 · Attovia Therapeutics, Inc.

$15.4K

—

ATTOSell

2026-08-05 · Attovia Therapeutics, Inc.

$4.4K

—

ATTOSell

2026-08-05 · Attovia Therapeutics, Inc.

$9.6K

—

Newest 10 of 61 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

DT

Deep Track Biotechnology Master Fund, Ltd.

ATTO · last 2026-08-06

RG

Redmile Group, LLC

ATTO · last 2026-08-06

S

Sanofi

ATTO · last 2026-08-06

VG

venBio Global Strategic Fund IV, L.P.

ATTO · last 2026-08-06

WC

Walsh Colin

ATTO · last 2026-08-06

BM

Blitzer Michael

MRLN · last 2026-05-20

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.